中国医药
中國醫藥
중국의약
CHINA MEDICINE
2012年
3期
311-313
,共3页
贾海梅%郑能雄%王镜泉%姚栩%陈杨伟%林丽芳%王丽红
賈海梅%鄭能雄%王鏡泉%姚栩%陳楊偉%林麗芳%王麗紅
가해매%정능웅%왕경천%요허%진양위%림려방%왕려홍
茶多酚%茶色素%茶氨酸%茶多糖%肝癌细胞
茶多酚%茶色素%茶氨痠%茶多糖%肝癌細胞
다다분%다색소%다안산%다다당%간암세포
Tea polyphenol%Tea pigment%Theanine%Tea polysaccharide%Liver cancer cell
目的 通过探讨茶及其有效成分对肝癌细胞HepG2增殖的影响,为乌龙茶成分进一步开发提供有力的实验室证据.方法 体外培养人肝癌细胞株HepG2,加入浓度为25、50、100和200 mg/L的茶叶浸出液、茶多酚、茶色素、茶多糖、茶氨酸作用24h后,用水溶性四唑盐(WST-1)检测肝癌细胞的存活率.结果 乌龙茶及其有效成分对肝癌细胞HepG2进行干预后,各组肝癌细胞的增殖均被抑制,各组的吸光度值均低于阴性对照组,茶汤100 mg/L组和200 mg/L组、茶多酚各组和茶色素各组、茶多糖和茶氨酸50mg/L、100 mg/L和200 mg/L组,与阴性对照组比较,差异均有统计学意义(均P<0.05).同时茶多酚25 mg/L组、茶色素25 mg/L组与茶汤25 mg/L组比较,差异均有统计学意义[(0.1658±0.0025)、(0.1913±0.0013)比(0.2005±0.0013),均P<0.05];茶多酚50mg/L组、茶色素50mg/L组、茶多糖50 mg/L组、茶氨酸50 mg/L组与茶汤50 mg/L组比较,差异均有统计学意义[(0.1545±0.0041)、(0.1655±0.0039)、(0.1595±0.0019)、(0.1728 ±0.0040)比(0.1970 ±0.0078),均P<0.05];茶多酚100 mg/L组(0.1370±0.0016)与茶汤100 mg/L组(0.1600 ±0.0037)比较,差异有统计学意义(P<0.05).结论 乌龙茶及其有效成分对人肝癌细胞HepG2具有明显的抑制作用,表现出抗肝癌的作用.
目的 通過探討茶及其有效成分對肝癌細胞HepG2增殖的影響,為烏龍茶成分進一步開髮提供有力的實驗室證據.方法 體外培養人肝癌細胞株HepG2,加入濃度為25、50、100和200 mg/L的茶葉浸齣液、茶多酚、茶色素、茶多糖、茶氨痠作用24h後,用水溶性四唑鹽(WST-1)檢測肝癌細胞的存活率.結果 烏龍茶及其有效成分對肝癌細胞HepG2進行榦預後,各組肝癌細胞的增殖均被抑製,各組的吸光度值均低于陰性對照組,茶湯100 mg/L組和200 mg/L組、茶多酚各組和茶色素各組、茶多糖和茶氨痠50mg/L、100 mg/L和200 mg/L組,與陰性對照組比較,差異均有統計學意義(均P<0.05).同時茶多酚25 mg/L組、茶色素25 mg/L組與茶湯25 mg/L組比較,差異均有統計學意義[(0.1658±0.0025)、(0.1913±0.0013)比(0.2005±0.0013),均P<0.05];茶多酚50mg/L組、茶色素50mg/L組、茶多糖50 mg/L組、茶氨痠50 mg/L組與茶湯50 mg/L組比較,差異均有統計學意義[(0.1545±0.0041)、(0.1655±0.0039)、(0.1595±0.0019)、(0.1728 ±0.0040)比(0.1970 ±0.0078),均P<0.05];茶多酚100 mg/L組(0.1370±0.0016)與茶湯100 mg/L組(0.1600 ±0.0037)比較,差異有統計學意義(P<0.05).結論 烏龍茶及其有效成分對人肝癌細胞HepG2具有明顯的抑製作用,錶現齣抗肝癌的作用.
목적 통과탐토다급기유효성분대간암세포HepG2증식적영향,위오룡다성분진일보개발제공유력적실험실증거.방법 체외배양인간암세포주HepG2,가입농도위25、50、100화200 mg/L적다협침출액、다다분、다색소、다다당、다안산작용24h후,용수용성사서염(WST-1)검측간암세포적존활솔.결과 오룡다급기유효성분대간암세포HepG2진행간예후,각조간암세포적증식균피억제,각조적흡광도치균저우음성대조조,다탕100 mg/L조화200 mg/L조、다다분각조화다색소각조、다다당화다안산50mg/L、100 mg/L화200 mg/L조,여음성대조조비교,차이균유통계학의의(균P<0.05).동시다다분25 mg/L조、다색소25 mg/L조여다탕25 mg/L조비교,차이균유통계학의의[(0.1658±0.0025)、(0.1913±0.0013)비(0.2005±0.0013),균P<0.05];다다분50mg/L조、다색소50mg/L조、다다당50 mg/L조、다안산50 mg/L조여다탕50 mg/L조비교,차이균유통계학의의[(0.1545±0.0041)、(0.1655±0.0039)、(0.1595±0.0019)、(0.1728 ±0.0040)비(0.1970 ±0.0078),균P<0.05];다다분100 mg/L조(0.1370±0.0016)여다탕100 mg/L조(0.1600 ±0.0037)비교,차이유통계학의의(P<0.05).결론 오룡다급기유효성분대인간암세포HepG2구유명현적억제작용,표현출항간암적작용.
Objective To study the effect of oolong tea and tea ingredients on liver cancer.Methods The human hepatoma cell line G2 (HepG2) was incubated in RPMI1640.HepG2 was exposed to oolong tea and tea polyphenol,tea pigment,theanine and tea polysaccbaride at the different concentrations of 25 mg/L,50 mg/L,100 mg/L and 200 mg/L for 24 hours,respectively.The growth inhibition of HepG2 cells was measured by WST-1 assay.Results The concentrations of tea in the 100 mg/L and 200mg/L groups were significantly lower than those in control group(P <0.05).The concentrations of tea polyphenol,tea pigment in 25 mg/L,50 mg/L,100 mg/L and 200 mg/L groups were significantly lower than control group(0.2017 ± 0.0018 ) (P < 0.05 ).The concentrations of theanine and tea polysaccharide in the 50 mg/L(0.1595 ±0.0019,0.1728 ± 0.0040),100 mg/L(0.1453 ± 0.0017,0.1555 ± 0.0045)and 200 mg/L groups(0.1305 ± 0.0024,0.1405 ± 0.0013 )were significantly lower than those in control group( P < 0.05 ).The concentrations of tea polyphenol ( 0.1658 ± 0.0025 ) and tea pigment ( 0.1913 ±0.0013 ) groups were significantly lower than those in tea group in the 25 mg/L (0.2005 ± 0.0013 ) ( P < 0.05 ).The concentrations of tea polyphenol(0.1545 ± 0.0041 ),tea pigment (0.1655 ± 0.0039 ),theanine (0.1595 ± 0.0019 ) and tea polysaccbaride(0.1728 ± 0.0040) were significantly lower than those in tea group(0.1970 ± 0.0078 )in the 50 mg/L( P <0.05 ).The concentrations of tea polyphenol (0.137 ± 0.0016)were significantly lower than those of tea group in the 100 mg/L(0.160 ± 0.0037)( P < 0.05 ).Conclusions The results indicate that oolong tea and tea ingredients can inhibit the proliferation on HepG2 cells.It is suggested that oolong tea and tea ingredients can be used to treat human liver carcinoma.